samedan logo
 
 
spacer
home > pmps > summer 2002 > mes or mess? - the creation of management information and the effective use of production data in pharmaceutical manufacturing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

MES or Mess? - The Creation of Management Information and the Effective Use of Production Data in Pharmaceutical Manufacturing

As a participant in the IT industry and one that has implemented a wide variety of production information systems in several industries, I have seen all too many buzzwords come and go. The name of the game today is management execution systems (MES). According to the hype, MES delivers totally integrated information systems from the production line to the boardroom - a thrilling thought! This article will look at the different areas that are involved in MES and analyse the different data and information needs from the various participants in the production, delivery and decision processes.

Although Table 1 is not exhaustive - neither when it comes to describing the needs of each and every role, nor all the possible roles involved in the production process - it is sufficient for the purpose of analysing the various aspects of an MES system and the fundamental differences in information needs throughout the information chain.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Espen Gisvold, Managing Director of ESGH Espen Gisvold is the Managing Director of ESGH. He graduated from the University of Oslo, Norway in 1985 in Mathematics, Physics and Informatics and gained a Bachelor's degree in Informatics, which focused on numerical analysis.
Subsequently, Espen spent 10 years working with Saga Petroleum ASA, where he subsequently established and was responsible for the production information management system for the operations division. In 1996, Espen joined Inenco - a software house specialising in MES systems - as Product Quality Manager. In May 2000, he moved to Agilent Technologies as Test Lead Engineer.

spacer
Espen Gisvold
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Myonex Opens New Global Headquarters

Myonex, a leading global clinical trial supply company, marked the opening of its new global headquarters and US operational facility with a ribbon-cutting ceremony on the company’s 14-acre campus.
More info >>

White Papers

Soothing the Logistical Headache of Clinical Trials

Equilibrium Travel Management

As many as 30 per cent of subjects on phase three clinical studies drop out.  Gruelling schedules, high travel costs and time waiting for expense reimbursement can all be factors in these fall rates, and this can be very problematic, delaying or even leading to the cancellation of the trial.  It is crucial to keep subjects motivated, and through efficient travel and expense management, this can be achieved.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement